AGN 194204 is a highly selective and potent Retinoid X Receptor (RXR) agonist known for its ability to modulate gene expression through heterodimerization with nuclear receptors, including PPARs. This… Read more
AGN 194204 is a highly selective and potent Retinoid X Receptor (RXR) agonist known for its ability to modulate gene expression through heterodimerization with nuclear receptors, including PPARs. This compound is the subject of ongoing research for its potential therapeutic applications in oncology, inflammatory conditions, and various nervous system disorders, such as Parkinson's disease. Within this category, laboratories can find essential reference standards, impurities, metabolites, and stable isotope-labelled compounds necessary for rigorous pharmaceutical analysis. These high-quality reference materials are critical for impurity profiling, method validation, and routine quality control, ensuring that analytical assays remain accurate and compliant with regulatory standards throughout the drug development process. By utilizing these characterized compounds, researchers and analytical chemists can reliably monitor purity, confirm structural integrity, and quantify potential by-products in AGN 194204 samples.